PYPD Gains 28.72%

PYPD (PYPD:NASDAQ) soared at $13.58, a gain of 28.7%. On Wed 14 Oct 20, PYPD:NASDAQ touched a New 2-Week Intraday Low of $9.81. The stock got featured on our News Catalysts scanner on Fri 09 Oct 20 at 04:47 AM in the 'BIOTECH' category. From Wed 30 Sep 20, the stock recorded 40.00% Up Days and 18.18% Green Days

The share price of the company has been moving sideways in recent weeks.

About PYPD (PYPD:NASDAQ)

PolyPid Ltd was incorporated under the laws of Israel and commenced its operations on February 28, 2008. The Company is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.